No Vitamin D Deficiency in Patients with Parkinson’s Disease

References

• Müller T, Lohse L, Blodau A, Frommholz K. Vitamin D rise enhances blood perfusion in patients with multiple sclerosis. J Neural Transm. 2019;126:1631–1636. doi:10.1007/s00702-019-02093-x
   PubMed Web of Science ®Google Scholar
• Lv Z, Qi H, Wang L, et al. Vitamin D status and Parkinson’s disease: a systematic review and meta-analysis. Neurol Sci. 2014;35:1723–1730. doi:10.1007/s10072-014-1821-6
   PubMed Web of Science ®Google Scholar
• Fullard ME, Duda JE. A Review of the Relationship Between Vitamin D and Parkinson Disease Symptoms. Front Neurol. 2020;11:454. doi:10.3389/fneur.2020.00454
   PubMed Web of Science ®Google Scholar
• Luo X, Ou R, Dutta R, Tian Y, Xiong H, Shang H. Association Between Serum Vitamin D Levels and Parkinson’s Disease: a Systematic Review and Meta-Analysis. Front Neurol. 2018;9:909. doi:10.3389/fneur.2018.00909
   PubMed Web of Science ®Google Scholar
• Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Saaksjarvi K, Heliovaara M. Serum vitamin D and the risk of Parkinson disease. Arch Neurol. 2010;67:808–811. doi:10.1001/archneurol.2010.120
   PubMedGoogle Scholar
• Barichella M, Cereda E, Iorio L, et al. Clinical correlates of serum 25-hydroxyvitamin D in Parkinson’s disease. Nutr Neurosci. 2020;1:1–9.
   Google Scholar
• Liu Y, Zhang BS. Serum 25-hydroxyvitamin D predicts severity in Parkinson’s disease patients. Neurol Sci. 2014;35:67–71. doi:10.1007/s10072-013-1539-x
   PubMed Web of Science ®Google Scholar
• Tanaka K, Miyake Y, Fukushima W, et al. Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson’s disease in Japan. Neurosci Lett. 2017;643:97–102. doi:10.1016/j.neulet.2017.02.037
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhou R, Zhang Z, Li K. The Association Between Vitamin D Status, Vitamin D Supplementation, Sunlight Exposure, and Parkinson’s Disease: a Systematic Review and Meta-Analysis. Med Sci Monit. 2019;25:666–674. doi:10.12659/MSM.912840
   PubMed Web of Science ®Google Scholar
• Zhu D, Liu G-Y, Lv Z, Wen S-R, Bi S, Wang W-Z. Outdoor activity and vitamin D intake are inversely associated with Parkinson’s disease risk. J Zhejiang Univ Sci B. 2014;15(10):923–927. doi:10.1631/jzus.B1400005
   PubMed Web of Science ®Google Scholar
• Wang J, Yang D, Yu Y, Shao G, Wang Q. Vitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson’s Disease. Nutrients. 2016;8:142. doi:10.3390/nu8030142
   PubMed Web of Science ®Google Scholar
• Wang L, Evatt ML, Maldonado LG, et al. Vitamin D from different sources is inversely associated with Parkinson disease. Mov Disord. 2015;30:560–566. doi:10.1002/mds.26117
   PubMed Web of Science ®Google Scholar
• Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G. Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertens. 2018;24:9. doi:10.1186/s40885-018-0094-4
   PubMedGoogle Scholar
• Shoemaker TJ, Mowry EM. A review of vitamin D supplementation as disease-modifying therapy. Mult Scler. 2018;24:6–11. doi:10.1177/1352458517738131
   PubMed Web of Science ®Google Scholar
• van Den BF, Speelman AD, Samson M, Munneke M, Bloem BR, Verhaar HJ. Parkinson’s disease and osteoporosis. Age Ageing. 2013;42:156–162. doi:10.1093/ageing/afs161
   PubMed Web of Science ®Google Scholar
• van Den BF, Speelman AD, Van NM, et al. Bone mineral density and vitamin D status in Parkinson’s disease patients. J Neurol. 2013;260:754–760. doi:10.1007/s00415-012-6697-x
   PubMed Web of Science ®Google Scholar
• Liu Y, Li YW, Tang YL, et al. Vitamin D: preventive and therapeutic potential in Parkinson’s disease. Curr Drug Metab. 2013;14:989–993. doi:10.2174/1389200211314090005
   PubMed Web of Science ®Google Scholar
• Evatt ML. Beyond vitamin status: is there a role for vitamin d in Parkinson disease? Arch Neurol. 2010;67:795–797. doi:10.1001/archneurol.2010.123
   PubMedGoogle Scholar
• Evatt ML. Parkinson disease: low vitamin D and Parkinson disease--a causal conundrum. Nat Rev Neurol. 2014;10:8–9. doi:10.1038/nrneurol.2013.252
   PubMed Web of Science ®Google Scholar
• Santangelo G, Raimo S, Erro R, et al. Vitamin D as a possible biomarker of mild cognitive impairment in parkinsonians. Aging Ment Health. 2021;25:1998–2002. doi:10.1080/13607863.2020.1839860
   PubMed Web of Science ®Google Scholar
• Petersen MS, Bech S, Christiansen DH, Schmedes AV, Halling J. The role of vitamin D levels and vitamin D receptor polymorphism on Parkinson’s disease in the Faroe Islands. Neurosci Lett. 2014;561:74–79. doi:10.1016/j.neulet.2013.12.053
   PubMed Web of Science ®Google Scholar
• Zhang HJ, Zhang JR, Mao CJ, et al. Relationship between 25-Hydroxyvitamin D, bone density, and Parkinson’s disease symptoms. Acta Neurol Scand. 2019;140:274–280. doi:10.1111/ane.13141
   PubMed Web of Science ®Google Scholar
• Ferguson CC, Knol LL, Halli-Tierney A, Ellis AC. Dietary Supplement Use is High among Individuals with Parkinson Disease. South Med J. 2019;112:621–625. doi:10.14423/SMJ.0000000000001041
   PubMed Web of Science ®Google Scholar
• Fahn S, Elton R. Members of the UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, editors. Recent Developments in Parkinson’s Disease II. New York: Macmillan; 1987:153–163.
   Google Scholar
• Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–699. doi:10.1111/j.1532-5415.2005.53221.x
   PubMed Web of Science ®Google Scholar
• Brola W, Sobolewski P, Szczuchniak W, et al. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis. Eur J Clin Nutr. 2016;70:995–999. doi:10.1038/ejcn.2016.51
   PubMed Web of Science ®Google Scholar
• Ozturk EA, Gundogdu I, Tonuk B, et al. Bone mass and vitamin D levels in Parkinson’s disease: is there any difference between genders? J Phys Ther Sci. 2016;28:2204–2209. doi:10.1589/jpts.28.2204
   PubMedGoogle Scholar
• Ozturk EA, Gundogdu I, Tonuk B, Umay E, Kocer BG, Cakci A. Bone mineral density and serum vitamin D status in Parkinson’s disease: are the stage and clinical features of the disease important? Neurol India. 2020;68:394–400. doi:10.4103/0028-3886.283755
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Jetty V, Rothschild M, et al. Associations between Serum 25-hydroxyvitamin D and Lipids, Lipoprotein Cholesterols, and Homocysteine. N Am J Med Sci. 2016;8:284–290. doi:10.4103/1947-2714.187137
   PubMed Web of Science ®Google Scholar
• Siotto M, Filippi MM, Simonelli I, et al. Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability. Front Neurosci. 2019;13:86. doi:10.3389/fnins.2019.00086
   PubMed Web of Science ®Google Scholar
• Wise J. Low vitamin D is linked to faster cognitive decline in older adults. BMJ. 2015;351:h4916. doi:10.1136/bmj.h4916
   PubMedGoogle Scholar
• Gatti D, Idolazzi L, Fassio A. Vitamin D: not just bone, but also immunity. Minerva Med. 2016;107:452–460.
   PubMed Web of Science ®Google Scholar
• Iacopetta K, Collins-Praino LE, Buisman-Pijlman FTA, Liu J, Hutchinson AD, Hutchinson MR. Are the protective benefits of vitamin D in neurodegenerative disease dependent on route of administration? A systematic review. Nutr Neurosci. 2020;23:251–280. doi:10.1080/1028415X.2018.1493807
   PubMed Web of Science ®Google Scholar